Merck Completes Acquisition of Prometheus Biosciences, Inc.
Go back to Merck Completes Acquisition of Prometheus Biosciences, Inc.| Merck & Co. (NYSE: MRK) | Delayed: 147.59 +6.66 (4.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $140.93 | 52 Week High | $65.46 | |||
| Open | $144.62 | 52 Week Low | $47.97 | |||
| Day High | $149.26 | P/E | 100.40 | |||
| Day Low | $143.32 | EPS | $1.47 | |||
| Volume | 4,330,785 | |||||
| IGNYTA (NASDAQ: RXDX) | Delayed: 199.92 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $199.92 | 52 Week High | $15.20 | |||
| Open | $10.02 | 52 Week Low | $4.15 | |||
| Day High | $199.92 | P/E | N/A | |||
| Day Low | $199.92 | EPS | $-0.44 | |||
| Volume | 417,305 | |||||



